Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

This publication has 42 references indexed in Scilit:

• CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection
  AIDS, 2008
• Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
  The Lancet, 2007
• Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies
  AIDS, 2007
• Evidence of Ongoing Immune Reconstitution in Subjects with Sustained Viral Suppression following 6 Years of Lopinavir-Ritonavir Treatment
  Clinical Infectious Diseases, 2007
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection
  Nature Medicine, 2006
• CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
  The Lancet, 2006
• Determinants of CD4⁺T Cell Recovery during Suppressive Antiretroviral Therapy: Association of Immune Activation, T Cell Maturation Markers, and Cellular HIV‐1 DNA
  The Journal of Infectious Diseases, 2006
• Initiation of Highly Active Antiretroviral Therapy at CD4⁺T Lymphocyte Counts of >350 cells/mm³: Disease Progression, Treatment Durability, and Drug Toxicity
  Clinical Infectious Diseases, 2003
• Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?
  AIDS, 2003
• Effect of HIV on Thymic Function before and after Antiretroviral Therapy in Children
  The Journal of Infectious Diseases, 2000